AbbVie Exec Says Co. Expects More Bolt-On Deals Rather Than Large Transformational Deal Like Allergan; Co. Has Continued Interest In Building Out Obesity Assets And Is Open To Anything With A Differentiated Profile That Could Match Its Abbv-295

Benzinga · 5d ago

https://edge.media-server.com/mmc/p/qvczs2fg